Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009)

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 6, 2012, Pages 1009-1013

  Marimon J M ^a,b   Alonso, M ^a   Rolo, D ^b,c   Ardanuy, C ^b,c   Linares J ^b,c   Perez Trallero E ^a,b,d  

^a HOSPITAL DONOSTIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; PENICILLIN G; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONAL EVOLUTION; GENOTYPE; HUMAN; INCIDENCE; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; AGED; CLASSIFICATION; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; SEROTYPING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PNEUMOCOCCAL INFECTIONS; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84862578931     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1399-3     Document Type: Article

References (17)

1. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737-1746 (Pubitemid 36514704)
2. Centers for Disease Control and Prevention (CDC) (2005) Direct and indirect effects of routine vaccination of children with 7- valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54:893-897
3. Centers for Disease Control and Prevention (CDC) (2008) Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 57:144-148
4. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ (2008) Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 14:275-281 (Pubitemid 351213678)
5. Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L, Kaltoft M, Krogfelt K, Slotved HC, Christensen JJ, KonradsenHB (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50:329-337
6. Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J (2009) Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 64:507-510
7. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B; Active Bacterial Core Surveillance Team (2005) Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192:1988-1995 (Pubitemid 41681898)
8. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, SchaffnerW, Lexau C, Gershman K, Reingold A, FarleyM, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197:1016-1027 (Pubitemid 351590031)
9. Mahjoub-Messai F, Doit C, Koeck JL, Billard T, Evrard B, Bidet P, Hubans C, Raymond J, Levy C, Cohen R, Bingen E (2009) Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. J Clin Microbiol 47:837-840
10. Muñoz-Almagro C, Esteva C, de Sevilla MF, Selva L, Gene A, Pallares R (2009) Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect 59:75-82
11. Tarragó D, Aguilar L, García R, Gimenez MJ, Granizo JJ, Fenoll A (2011) Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother 55:2297-2302
12. Aguiar SI, Pinto FR, Nunes S, Serrano I, Melo-Cristino J, Sá-Leão R, Ramirez M, de Lencastre H (2010) Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J Clin Microbiol 48:101-108
13. Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB (2011) Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 203:1360-1368
14. Pérez-Trallero E, Marimon JM, Ercibengoa M, Vicente D, Pérez- Yarza EG (2009) Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 28:731-738
15. Marimon JM, Monasterio A, Ercibengoa M, Pascual J, Prieto I, Simón L, Perez-Trallero E (2010) Antibody microarray typing, a novel technique for Streptococcus pneumoniae serotyping. J Microbiol Methods 80:274-280
16. Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing: Twentieth Informational Supplement. CLSI document M100-S20. CLSI, Wayne, PA
17. Reinert R, Jacobs MR, Kaplan SL (2010) Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 28:4249-4259